Ghana has launched a National Sickle Cell Disease (SCD) Strategy aimed at strengthening the diagnosis, treatment, and management of sickle cell disease. This initiative marks a significant step in addressing the disease, which affects about 18,000 newborns annually and impacts close to 25% of the population who carry the gene.
At the strategy launch, Ghana’s Health Minister, Dr. Bernard Okoe Boye, stressed the need for comprehensive measures to reduce the prevalence of SCD-related complications, especially in children under five, adolescents, and pregnant women who are particularly vulnerable. The plan emphasizes genetic counseling and preventive screening, with hopes to reduce the heavy healthcare burden associated with SCD and improve life quality for affected individuals and their families.
Dr. Lawrence Osei Tutu, a pediatrician, highlighted the importance of newborn screening, noting that many children with SCD die before their condition is even diagnosed. The new strategy aims to prioritize early detection and mobilize resources to tackle challenges in managing SCD effectively.
Sickle cell disease is a genetic disorder affecting hemoglobin, with symptoms ranging from anemia and pain crises to organ damage. The launch event also introduced the 2022 National Vaccine Policy, emphasizing Ghana’s commitment to strengthening public health through enhanced preventive measures.